BELLUS Health Inc. (BLU)
NASDAQ: BLU
· Real-Time Price · USD
14.74
0.00 (0.00%)
At close: Jun 28, 2023, 9:59 PM
BELLUS Health Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 228.64M | 253M | 85.38M | 87.25M | 72.86M | 121.72M | 147.16M | 150.08M | 25.28M | 29.12M | 32.46M |
Short-Term Investments | 537.7M | 515.38M | 227.61M | 249.81M | 291.5M | 98.43M | 86.81M | 98.73M | 33.07M | 43.21M | 49.48M |
Long-Term Investments | 53.2M | 35.38M | 27.73M | 23.49M | 16.36M | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | -319.2M | -292.14M | -27.37M | -23.15M | -16.1M | 245K | 225K | 218K | 207K | 200K | 194K |
Receivables | 1.83B | 1.88B | 2.04M | 1.64M | 1.23M | 1.74M | 1.67M | 1.37M | 1.38M | 1.35M | 1.36M |
Inventory | n/a | 2.00 | n/a | n/a | 2.00 | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 63.45M | 63.27M | 12.68M | 17.19M | 12.5M | 10.38M | 9.37M | n/a | n/a | n/a | n/a |
Total Current Assets | 2.66B | 2.71B | 327.71M | 355.89M | 378.1M | 232.26M | 245.01M | 258.2M | 63.68M | 76.05M | 87.47M |
Property-Plant & Equipment | 55.41M | 49.67M | 1.2M | 1.31M | 646K | 719K | 791K | 853K | 365K | 410K | 456K |
Goodwill & Intangibles | 210.59M | 207.09M | 50.1M | 50.1M | 50.1M | 50.1M | 50.1M | 50.1M | 50.1M | 50.1M | 50.1M |
Total Long-Term Assets | 319.2M | 292.14M | 51.83M | 51.93M | 51.2M | 51.24M | 51.32M | 51.39M | 50.67M | 50.71M | 50.75M |
Total Assets | 3.09B | 3.12B | 379.54M | 407.82M | 429.3M | 283.5M | 296.33M | 309.6M | 114.35M | 126.75M | 138.22M |
Account Payables | 394.65M | 341.54M | 9.44M | 4.54M | 22.06M | 18.84M | 15.66M | 2.86M | 18.44M | 9.35M | 4.65M |
Deferred Revenue | n/a | n/a | -1.01B | n/a | -684.83M | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | n/a | n/a | 365K | 351K | 241K | 257K | 291K | 254K | 186K | 169K | 179K |
Other Current Liabilities | 1.37B | 1.46B | 1.01B | 10.98M | 684.83M | n/a | 26K | 13.84M | n/a | n/a | n/a |
Total Current Liabilities | 1.77B | 1.8B | 9.8M | 15.88M | 22.3M | 19.09M | 15.98M | 16.95M | 18.62M | 9.52M | 4.83M |
Long-Term Debt | 47.24M | 47.71M | 834K | 932K | 362K | 463K | 554K | 617K | 208K | 262K | 305K |
Other Long-Term Liabilities | -47.24M | -47.71M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | 47.24M | 47.71M | 834K | 932K | 362K | 463K | 554K | 617K | 208K | 262K | 305K |
Total Liabilities | 1.91B | 1.95B | 10.64M | 16.81M | 22.66M | 19.56M | 16.53M | 17.57M | 18.83M | 9.78M | 5.14M |
Total Debt | n/a | n/a | 1.2M | 1.28M | 603K | 720K | 845K | 871K | 394K | 431K | 484K |
Common Stock | 5.51M | 5.37M | 977.66M | 977.32M | 976M | 800.04M | 800.01M | 799.39M | 575.29M | 575.29M | 575.29M |
Retained Earnings | -1.49B | -1.41B | -666.9M | -641.84M | -623.67M | -587.45M | -568.68M | -554.32M | -525.29M | -502.41M | -484.58M |
Comprehensive Income | n/a | n/a | 9.3M | 9.3M | 9.3M | 9.3M | 9.3M | 9.3M | 9.3M | 9.3M | 9.3M |
Shareholders Equity | 1.18B | 1.17B | 368.9M | 391.01M | 406.64M | 263.94M | 279.79M | 292.03M | 95.52M | 116.98M | 133.09M |
Total Investments | 590.9M | 550.76M | 227.61M | 249.81M | 291.5M | 98.43M | 86.81M | 98.73M | 33.07M | 43.21M | 49.48M |